T. Supryadkina

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders

I. Dvoryashina, Дворяшина Ирина Владимировна, K. Kholmatova, 2014 .

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy.

G. Hovingh, P. Bogdański, R. Libis, 2022, Diabetes care.